Magnafodipir Trisodium for Edinburgh clinical studies, from IC Targets
- University of Edinburgh
- Scotland
- Award procedure without prior publication of a call for competition, 1 bid
The University of Edinburgh bought 200 units of Magnafodipir Trisodium, an MRI contrast agent.
The Institute for Neuroscience and Cardiovascular Disease needed it for clinical studies already under way. The material had to be clinical grade and fit for use in people.
The university awarded the £66,000 order directly to IC Targets AS, as the sole source, in May 2026.
- What
- Radiopharmaceuticals and contrast media
- Supplier
- IC Targets AS
- Value
- £66,000
- How it was bought
- Award procedure without prior publication of a call for competition
- 1 bid
- Dates and next
- 12 May 2026